Literature DB >> 10478990

Pharmacist recognition of potential drug interactions.

R A Weideman1, I H Bernstein, W P McKinney.   

Abstract

The ability of pharmacists to identify potential drug interactions was studied. Simulated medication profiles were created from a list of 16 drugs. Staff pharmacists and soon-to-graduate student pharmacists at a Veterans Affairs medical center each received a set of eight 2-drug profiles, four 4-drug profiles, two 8-drug profiles, and one 16-drug profile. Each set of profiles contained a number of pairs of drugs rated by the Drug Therapy Screening System as producing an interaction of moderate or major importance. The subjects were given one hour to screen the profile for the potentially interacting pairs. The subjects detected only 66% of the interactions in the 2-drug profiles, 34% of the interactions in the 4-drug profiles, 20% of the interactions in the 8-drug profiles, and 17% of the interactions in the 16-drug profile. None of the subjects detected all interactions in the 8- or 16-drug profiles. Both true-positive and false-positive rates of identification decreased significantly as the number of drugs listed on the profile increased. This primarily reflected a reduced tendency to report the presence of drug interactions, but there was additional evidence that the accuracy of identification also declined. The number of years of pharmacy training was the only demographic characteristic highly correlated with accuracy. More years of pharmacy education seemed to improve the ability to detect drug interactions. However, none of the pharmacists or students was able to detect all potentially interacting pairs in a profile containing 8 or 16 drugs. Computerized drug interaction profiles should be used by pharmacists to ensure recognition of all potential drug interactions.

Mesh:

Year:  1999        PMID: 10478990     DOI: 10.1093/ajhp/56.15.1524

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  23 in total

1.  Healthcare professional students' knowledge of drug-drug interactions.

Authors:  Amanda R Harrington; Terri L Warholak; Lisa E Hines; Ann M Taylor; Duane Sherrill; Daniel C Malone
Journal:  Am J Pharm Educ       Date:  2011-12-15       Impact factor: 2.047

2.  Evaluation of three brands of drug interaction software for use in intensive care units.

Authors:  Adriano Max Moreira Reis; Silvia Helena De Bortoli Cassiani
Journal:  Pharm World Sci       Date:  2010-10-21

3.  Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions.

Authors:  Kim R Saverno; Lisa E Hines; Terri L Warholak; Amy J Grizzle; Lauren Babits; Courtney Clark; Ann M Taylor; Daniel C Malone
Journal:  J Am Med Inform Assoc       Date:  2010-12-03       Impact factor: 4.497

4.  Clinical relevance of drug-drug interactions : a structured assessment procedure.

Authors:  Eric N van Roon; Sander Flikweert; Marianne le Comte; Pim N J Langendijk; Wilma J M Kwee-Zuiderwijk; Paul Smits; Jacobus R B J Brouwers
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 5.  Clinical risk management of herb-drug interactions.

Authors:  Peter A G M De Smet
Journal:  Br J Clin Pharmacol       Date:  2006-11-20       Impact factor: 4.335

6.  Response to Trujillo's article on "A Drug Interactions Elective Course".

Authors:  Elizabeth Anne Forsberg
Journal:  Am J Pharm Educ       Date:  2009-11-12       Impact factor: 2.047

7.  Pharmacy students' ability to identify potential drug-drug interactions.

Authors:  Kim R Saverno; Daniel C Malone; John Kurowsky
Journal:  Am J Pharm Educ       Date:  2009-04-07       Impact factor: 2.047

8.  Pharmacy students' retention of knowledge of drug-drug interactions.

Authors:  Adrienne M Gilligan; Terri L Warholak; John E Murphy; Lisa E Hines; Daniel C Malone
Journal:  Am J Pharm Educ       Date:  2011-08-10       Impact factor: 2.047

9.  Generating Evidence of Clinical Outcomes of Drug-Drug Interactions.

Authors:  Katsiaryna Bykov; Joshua J Gagne
Journal:  Drug Saf       Date:  2017-02       Impact factor: 5.606

10.  Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers.

Authors:  Yu Ko; Daniel C Malone; Grant H Skrepnek; Edward P Armstrong; John E Murphy; Jacob Abarca; Rick A Rehfeld; Sally J Reel; Raymond L Woosley
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.